Table 2.
Average equivalent and effective doses of 99mTc-CXCR4-L calculated from six healthy volunteers (3 females and 3 males).
| Target organ | Equivalent doses (mean ± SD) (mSv/MBq) | |
|---|---|---|
| Females | Males | |
| Adrenals | (8.93 ± 1.31) E − 06 | (8.38 ± 2.27) E − 06 |
| Brain | (3.32 ± 0.25) E − 06 | (3.54 ± 0.96) E − 06 |
| Breasts | (3.02 ± 0.64) E − 04 | (4.70 ± 0.26) E − 05 |
| Gallbladder wall | (1.59 ± 0.48) E − 04 | (1.00 ± 0.04) E − 04 |
| LLI wall | (6.10 ± 0.64) E − 04 | (6.10 ± 0.30) E − 04 |
| Small intestine | (2.05 ± 0.21) E − 05 | (1.71 ± 0.50) E − 05 |
| Stomach wall | (1.87 ± 0.14) E − 04 | (2.01 ± 0.47) E − 04 |
| ULI wall | (3.30 ± 0.45) E − 05 | (2.74 ± 0.80) E − 05 |
| Heart wall | (5.26 ± 0.64) E − 05 | (5.57 ± 0.53) E − 05 |
| Kidneys | (3.13 ± 0.57) E − 05 | (1.03 ± 0.89) E − 04 |
| Liver | (1.41 ± 0.36) E − 04 | (1.46 ± 0.16) E − 04 |
| Lungs | (4.37 ± 0.90) E − 04 | (4.71 ± 0.57) E − 04 |
| Muscle | (5.81 ± 0.46) E − 06 | (5.41 ± 1.56) E − 06 |
| Ovaries | (5.63 ± 0.16) E − 04 | (0.00 ± 0.00) E+00 |
| Pancreas | (9.13 ± 0.12) E − 06 | (8.35 ± 2.29) E − 06 |
| Red marrow | (1.46 ± 0.01) E − 04 | (1.67 ± 0.05) E − 04 |
| Osteogenic cells | (2.68 ± 0.22) E − 05 | (3.18 ± 0.09) E − 05 |
| Skin | (6.57 ± 0.59) E − 06 | (7.67 ± 0.25) E − 06 |
| Spleen | (7.35 ± 0.80) E − 06 | (7.02 ± 1.84) E − 06 |
| Testes | (0.00 ± 0.00) E+00 | (1.75 ± 0.07) E − 03 |
| Thymus | (6.22 ± 0.77) E − 06 | (5.63 ± 1.70) E − 06 |
| Thyroid | (3.88 ± 0.36) E − 05 | (5.45 ± 0.16) E − 05 |
| Urinary bladder wall | (7.76 ± 1.15) E − 04 | (4.06 ± 0.90) E − 04 |
| Uterus | (1.52 ± 0.06) E − 05 | (1.15 ± 0.38) E − 05 |
| Effective dose (mSv/MBq) | (3.59 ± 0.29) E − 03 | (4.24 ± 0.21) E − 03 |